Guobang Pharma Ltd - Asset Resilience Ratio

Latest as of March 2026: 11.00%

Guobang Pharma Ltd (605507) has an Asset Resilience Ratio of 11.00% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

CN¥1.25 Billion

≈ $183.44 Million USD Cash + Short-term Investments

Total Assets

CN¥11.40 Billion

≈ $1.67 Billion USD All company assets

Resilience Assessment

Moderate

Financial Resilience Level

Asset Resilience Ratio Trend (2019–2025)

This chart shows how Guobang Pharma Ltd's Asset Resilience Ratio has changed over time. See financial agility of Guobang Pharma Ltd to measure the company's free cash flow as a share of total liabilities.

Liquid Assets Composition Over Time

This chart breaks down Guobang Pharma Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see market cap of Guobang Pharma Ltd.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥1.25 Billion	11.0%
Total Liquid Assets	CN¥1.25 Billion	11.00%

Asset Resilience Insights

Moderate Liquidity: Guobang Pharma Ltd has 11.00% of assets in liquid form.
While adequate for normal operations, this level may limit flexibility during economic stress.
The company has significant short-term investments, indicating active treasury management.

Guobang Pharma Ltd Industry Peers by Asset Resilience Ratio

Compare Guobang Pharma Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt F:RIG2	Drug Manufacturers - Specialty & Generic	0.20%
JW Pharmaceutical Corp KO:001067	Drug Manufacturers - Specialty & Generic	8.17%
Jiangsu Hengrui Medicine Co Ltd SHG:600276	Drug Manufacturers - Specialty & Generic	0.16%
Shijiazhuang Yiling Pharmaceutical Co Ltd SHE:002603	Drug Manufacturers - Specialty & Generic	11.60%
Guilin Sanjin Pharmaceutical Co Ltd SHE:002275	Drug Manufacturers - Specialty & Generic	14.80%
Fuan Pharmaceutical Group Co SHE:300194	Drug Manufacturers - Specialty & Generic	1.34%
DRI Healthcare Trust TO:DHT-U	Drug Manufacturers - Specialty & Generic	13.91%
Hainan Shuangcheng Pharmaceut SHE:002693	Drug Manufacturers - Specialty & Generic	1.03%

Annual Asset Resilience Ratio for Guobang Pharma Ltd (2019–2025)

The table below shows the annual Asset Resilience Ratio data for Guobang Pharma Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	11.32%	CN¥1.24 Billion ≈ $181.88 Million	CN¥10.98 Billion ≈ $1.61 Billion	+5.59pp
2024-12-31	5.73%	CN¥617.66 Million ≈ $90.38 Million	CN¥10.78 Billion ≈ $1.58 Billion	+1.23pp
2023-12-31	4.50%	CN¥465.99 Million ≈ $68.19 Million	CN¥10.36 Billion ≈ $1.52 Billion	-4.62pp
2022-12-31	9.12%	CN¥824.56 Million ≈ $120.66 Million	CN¥9.04 Billion ≈ $1.32 Billion	-7.63pp
2021-12-31	16.75%	CN¥1.26 Billion ≈ $184.12 Million	CN¥7.51 Billion ≈ $1.10 Billion	+16.75pp
2020-12-31	0.00%	CN¥34.78K ≈ $5.09K	CN¥5.51 Billion ≈ $806.08 Million	-3.15pp
2019-12-31	3.15%	CN¥149.87 Million ≈ $21.93 Million	CN¥4.76 Billion ≈ $696.45 Million	--

pp = percentage points

About Guobang Pharma Ltd

SHG:605507 China Drug Manufacturers - Specialty & Generic

Market Cap

$1.26 Billion

CN¥8.59 Billion CNY

Market Cap Rank

#7918 Global

#1802 in China

Share Price

CN¥15.37

Change (1 day)

-3.33%

52-Week Range

CN¥14.70 - CN¥29.25

All Time High

CN¥43.71